Asks Govt to Fie Status Report Within Week
SRINAGAR: The Jammu and Kashmir High Court Wednesday directed the Chief Secretary to supervise the investigations into the spurious drug scam being conducted by the Crime Branch.
The Division Bench of the HC comprising of Justice Mansoor Ahmad Mir and Justice Ali Muhammad Margay asked the Inspector General of Police, Crime Branch to personally conduct the investigation under the supervision of Chief Secretary.
The Court has directed the Chief Secretary to supervise the investigations conducted by the Crime Branch, advocate Fayaz Ahamd Bhat who represents the petitioners - Doctors Association of Kashmir - said.
Sources said that the High Court Bar Association is contemplating to file a separate PIL in the case. We are thinking to file a separate Public Interest Litigation (PIL) before the High Court, a member of the Bar who wished anonymity said.
However, the DAK negated the news about a separate PIL. They (Bar) are helping us and do not have an plans to file a separate PIL, DAK President, Dr Nisar-u-Hassan said.
The scam surfaced earlier this month after it was exposed that two life saving drugs supplied to Kashmir hospitals - antibiotic Maximizen-625 and Curesef - were found of substandard quality.The complainant stated in the Court that sample of Maximizen lifted was found not to be of standard quality.
Subsequently it came to fore that two lakh tablets of the drug manufactured by M/s Life Line Pharmaco Surgicals, Dream City Mutthi Jammu were supplied to the hospitals in Jammu and Kashmir.
Accordingly drug alert notice was issued by the Deputy Drug Controller Kashmir to all the districts regarding the spurious/substandard drugs and the Drug Inspectors tracked the distribution pattern of the substandard drug and got seized about 34,916 tablets from different.
The TADA Court, designated as Special Court to hear cases related to spurious and adulterated drugs, passed the directions on a complaint filed by the state through Drug Inspector, Zone-VI, Srinagar, seeking directions for action against the accused for offences related to supply of spurious drugs.
Special Magistrate, Muzaffar Iqbal Qureshi directed the Concerned SSPs to execute the non-bailable warrants after standing counsel for Drug Control, Musavir Wani argued that the accused have violated various sections of Drugs and Cosmetics Act 1940 and deserve to be punished.
The accused persons and companies alleged to be involved in the spurious drug trade were identified are Akhil Gadoo of Tomal Colony Bohri Jammu, Amardeep Raina of Muthi Jammu, Ashok Kumar Raina of Muthi Jammu (Proprietors of M/S Life Line Pharmaco- Surgicals), Prem Prakash Barnwal of Uttar-Pradesh (Director of M/S Sanative Pharmaceuticals Pvt Ltd), Manjula Barnwal of UP (Director M/S Sanative Pharmaceuticals Pvt Ltd), Asok Kumar of Dehradun (Analytical Chemist of M/S Sanative Pharmaceuticals Pvt Ltd), Manoj Kumar Agarwal of Patna-Bihar (Director M/S Sanative Pharmaceuticals Pvt Ltd), Rahul Kumar Singh of Dehradun (Managing Director M/S Medley Pharmaceuticals Pvt Ltd Medley House of Mumbai), Arvind Billa (Proprietor of M/S Affy Parenterals Village Gullerwala of Himachal Pradesh), Vilas Bhimarao Thorat of Himachal Pradesh (Manufacturing Chemist of M/S Affy Parenterals Village Gullerwala), Suneet Bhardwaj of Himachal Pradesh (Manufacturing Chemist of M/S Affy Parenterals Village Gullerwala), Bipin Kumar of Himachal Pradesh (Analytical Chemist of M/S Affy Parenterals), Sanjay Mishra of Himachal Pradesh (Manufacturing Chemist of M/S Affy Parenterals Vill.Gullerwala) and Suraj Enterprises.
Following the surfacing of the drug scam the state government handed over the case to the Crime Branch for investigation.
Be Part of Quality Journalism
Quality journalism takes a lot of time, money and hard work to produce and despite all the hardships we still do it. Our reporters and editors are working overtime in Kashmir and beyond to cover what you care about, break big stories, and expose injustices that can change lives. Today more people are reading Kashmir Observer than ever, but only a handful are paying while advertising revenues are falling fast.